E-LIB Suche - Ergebnisse für: Silverman, Rachel A. - Sprache EN

Search for persons X

Sorted by: Relevance

Sorted by: Year

1

COVID-19 related messaging, beliefs, information sources, a..:

Silverman, Rachel A. ; Short, Danielle ; Wenzel, Sophie..
PeerJ. 12 (2024) - p. e16714 , 2024

Link: https://doi.org/10.7717/..

2

Walking the talk

Reimagining primary health care after COVID-19

Baris, Enis ; Pate, Muhammad Ali ; Silverman, Rachel.. , 2022

Link: http://elibrary.worldban..

3

Vaccine Effectiveness during Outbreak of COVID-19 Alpha (B...:

Silverman, Rachel A. ; Ceci, Alessandro ; Cohen, Alasdair...
Emerging Infectious Diseases. 28 (2022) 7 - p. 1313-1320 , 2022

Link: https://doi.org/10.3201/..

4

How Should the World Pay for a Coronavirus Disease (COVID-1..:

Towse, Adrian ; Chalkidou, Kalipso ; Firth, Isobel..
Value in Health. 24 (2021) 5 - p. 625-631 , 2021

Link: https://doi.org/10.1016/..

5

Value-based tiered pricing for universal health coverage: a..:

Chalkidou, Kalipso ; Claxton, Karl ; Silverman, Rachel.
Gates Open Research. 4 (2020) - p. 16 , 2020

Link: https://doi.org/10.12688..

6

Value-based tiered pricing for universal health coverage: a..:

Chalkidou, Kalipso ; Claxton, Karl ; Silverman, Rachel.
Gates Open Research. 4 (2020) - p. 16 , 2020

Link: https://doi.org/10.12688..

7

Value-based tiered pricing for universal health coverage: a..:

Chalkidou, Kalipso ; Claxton, Karl ; Silverman, Rachel.
Gates Open Research. 4 (2020) - p. 16 , 2020

Link: https://doi.org/10.12688..

8

Market-driven, value-based, advance commitment (MVAC): acce..:

Chalkidou, Kalipso ; Towse, Adrian ; Silverman, Rachel..
BMJ Global Health. 5 (2020) 4 - p. e002061 , 2020

Link: https://doi.org/10.1136/..

9

Predictors of mortality within the first year of initiating..:

Silverman, Rachel A. ; John-Stewart, Grace C. ; Beck, Ingrid A....
PLOS ONE. 14 (2019) 10 - p. e0223411 , 2019

Link: https://doi.org/10.1371/..

10

Permutation and Bootstrap Testing for the Sequential Parall..:

Silverman, Rachel ; Fine, Jason ; Zink, Richard C..
Statistics in Biopharmaceutical Research. 11 (2019) 1 - p. 44-51 , 2019

Link: https://doi.org/10.1080/..

11

Prevalence of Pre-antiretroviral-Treatment Drug Resistance ..:

Silverman, Rachel A ; Beck, Ingrid A ; Kiptinness, Catherine...
The Journal of Infectious Diseases. 216 (2017) 12 - p. 1569-1578 , 2017

Link: https://doi.org/10.1093/..

12

Prevalence of Pre-antiretroviral-Treatment Drug Resistance ..:

Silverman, Rachel A. ; Beck, Ingrid A. ; Kiptinness, Catherine...
The Journal of Infectious Diseases. 216 (2017) 12 - p. 1569-1578 , 2017

Link: https://www.jstor.org/st..

13

Uncertainty analysis of geothermal well drilling and comple..:

Lukawski, Maciej Z. ; Silverman, Rachel L. ; Tester, Jefferson W.
Geothermics. 64 (2016) - p. 382-391 , 2016

Link: https://doi.org/10.1016/..

14

How to Get Cost-Effectiveness Analysis Right? The Case of V..:

Glassman, Amanda ; Cañón, Oscar ; Silverman, Rachel
Value in Health. 19 (2016) 8 - p. 913-920 , 2016

Link: https://doi.org/10.1016/..

15

Persistence of HIV Drug Resistance Among South African Chil..:

Kanthula, Ruth ; Beck, Ingrid ; Dyk, Gisela Van...
Open Forum Infectious Diseases. 2 (2015) suppl_1 - p. , 2015

Link: https://doi.org/10.1093/..

1-15